SCOTT HIRST: Open Payments
NPI 1194489294 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 25 payments from 5 companies in 2025. Trend: 2023 $470 · 2024 $569 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 17 | $479 |
| Gilead Sciences, Inc. | 4 | $72 |
| ABBVIE INC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: RUKOBIA, CABENUVA, APRETUDE, DOVATO, MAVYRET, PIFELTRO, SHINGRIX.
Industry payments across NJ — which companies pay providers there.
